Fuji Pharma Co., Ltd. (4554.T) — Stock Score Summary

Fuji Pharma Co., Ltd. (4554.T) has a MoatMap StockRank of 98/100 based on Quality (56/100), Value (64/100), and Momentum (76/100) factor scores. The current signal is STRONG BUY.

Key Financial Metrics

Price$13.65
Market Cap$362M
P/E (TTM)22.42
P/E (Forward)14.25
Price/Book1.13
Return on Equity5.0%
Return on Invested Capital6.9%
Debt/Equity57.66
Gross Margin40.5%
Operating Margin11.7%
Revenue Growth24.6%
Dividend Yield2.2%
Free Cash Flow$182K

Fuji Pharma Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Japan).

Frequently Asked Questions

What is Fuji Pharma Co., Ltd.’s (4554.T) StockRank?
MoatMap’s StockRank for Fuji Pharma Co., Ltd. (4554.T) is 98/100, with a Strong Buy signal. It is a composite of Quality (56), Value (64), and Momentum (76) factor ranks across MoatMap’s 19,000+ stock universe.
Does Fuji Pharma Co., Ltd. have an economic moat?
Fuji Pharma Co., Ltd. (4554.T) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Fuji Pharma Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Fuji Pharma Co., Ltd. (4554.T) is Strong Buy, based on a StockRank of 98/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Fuji Pharma Co., Ltd. in?
Fuji Pharma Co., Ltd. (4554.T) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Japan).